b'Scientific Session Abstracts SUNDAY APRIL 21, 2024Table I. Patient characteristics, operative metrics, and outcomesfrom PM-FBEVAR in CEVAROutcomeTotal patients 10Male sex 8 (80%)Age (years) 74.68.5Aneurysm diameter at PM-FBEVAR (mm) 71.812.8Indication for FB-EVAR in FEVARFailed ZFEN 4 (40%)Failed parallel grafting/snorkel 3 (30%)Failed PM-FBEVAR 3 (30%)Target vessels on redo PM-FBEVAR [median, IQR] 4 [0]Procedure time (min) 26161.3Contrast (cc) 10731.9Fluoroscopy time (min) 67.219Technical success 8 (80%)Celiac fenestration misalignment 1Renal fenestration used for aberrant commonhepatic artery 130-day mortality 0 (0%)Major adverse eventsAKI 1 (10%)Cardiac event 0 (0%)Respiratory failure 0 (0%)Bowel ischemia 0 (0%)Stroke 0 (0%)Spinal cord ischemia 0 (0%)Follow-up (months) 18.212.3ReinterventionsEndoleak reintervention 3 (30%)Target vessel stenosis/thrombosis reintervention 2 (20%)All-cause mortality 2 (20%)42 NDANNUAL MEETING|APRIL 1921, 2024|OCEANSIDE, CA 75'